JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Musser, B.
Right arrow Articles by Vestal, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musser, B.
Right arrow Articles by Vestal, R. E.

Vol. 288, Issue 2, 446-454, February 1999

Adenosine A1 Receptor-Dependent and -Independent Effects of the Allosteric Enhancer PD 81,7231

Beth Musser, Ramagopal V. Mudumbi , Jingwen Liu2 , Richard D. Olson and Robert E. Vestal

Clinical Pharmacology and Gerontology Research Unit, Department of Veterans Affairs Medical Center, Boise, Idaho (B.M., R.V.M., J.L., R.D.O., R.E.V.); Mountain States Medical Research Institute, Boise, Idaho (R.V.M., J.L., R.D.O., R.E.V.); and Department of Medicine and Pharmacology, University of Washington School of Medicine, Seattle, Washington (R.D.O., R.E.V.)

The 2-amino-3-benzoylthiophene PD 81,723 has been shown to exhibit allosteric enhancement of adenosine A1 receptor binding and function. The aim of this study was to clarify the mechanism of this effect using membranes purified from rat brain and Chinese hamster ovary (CHO)-A1 cells that stably express the rat adenosine A1 receptor as well as intact CHO-A1 and nontransfected CHO cells. In membranes containing 100 µM magnesium, (2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone (PD 81,723) significantly increased the affinity of the adenosine A1 receptor agonist, cyclopentyladenosine, for the low-affinity receptor without affecting high-affinity binding or Bmax. In intact cells, PD 81,723 inhibited basal adenylyl cyclase (AC) activity as well as forskolin-, cholera toxin-, and pertussis toxin-stimulated AC activity in CHO-A1 and CHO cells. Basal AC activity was inhibited 49% in CHO and 82% in CHO-A1 cells by 30 µM PD 81,723. In CHO-A1 cells, half-maximal inhibition of forskolin-stimulated AC occurred at 5 µM PD 81,723 compared to 10 µM in CHO cells. Cholera toxin-stimulated AC was reduced 90% in both CHO and CHO-A1 cells by 30 µM PD 81,723. At the same concentration of PD 81,723, pertussis toxin-stimulated AC activity was reduced 86% (CHO-A1) and 77% (CHO). [3H]forskolin was displaced from purified rat liver AC by PD 81,723 with an IC50 of 96 µM. These results demonstrate that two mechanisms appear to contribute to the observed effects of PD 81,723. One mechanism is allosteric enhancement of adenosine A1 receptor function. Results from transfected and nontransfected cells suggest that PD 81,723 also inhibits AC directly by binding to the catalytic unit at or near the forskolin-binding site.


0022-3565/99/2882-0446$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. Figler, R. A. Olsson, and J. Linden
Allosteric Enhancers of A1 Adenosine Receptors Increase Receptor-G Protein Coupling and Counteract Guanine Nucleotide Effects on Agonist Binding
Mol. Pharmacol., December 1, 2003; 64(6): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Swaminath, T. W. Lee, and B. Kobilka
Identification of an Allosteric Binding Site for Zn2+ on the beta 2 Adrenergic Receptor
J. Biol. Chem., January 3, 2003; 278(1): 352 - 356.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Swaminath, J. Steenhuis, B. Kobilka, and T. W. Lee
Allosteric Modulation of beta 2-Adrenergic Receptor by Zn2+
Mol. Pharmacol., January 1, 2002; 61(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Knoflach, V. Mutel, S. Jolidon, J. N. C. Kew, P. Malherbe, E. Vieira, J. Wichmann, and J. A. Kemp
Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site
PNAS, October 16, 2001; (2001) 231358298.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Leppik and N. J. M. Birdsall
Agonist Binding and Function at the Human alpha 2A-Adrenoceptor: Allosteric Modulation by Amilorides
Mol. Pharmacol., November 1, 2000; 58(5): 1091 - 1099.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Knoflach, V. Mutel, S. Jolidon, J. N. C. Kew, P. Malherbe, E. Vieira, J. Wichmann, and J. A. Kemp
Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site
PNAS, November 6, 2001; 98(23): 13402 - 13407.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.